Disrupted WNT5B signaling leads to the progression of diseases such as osteoarthritis, osteoporosis, obesity, type 2 diabetes mellitus and chronic diseases associated with aging, as well as cancers. This evidence concerns the gene WNT5B and obesity due to melanocortin 4 receptor deficiency.